Inogen | INGN - Assets


Inogen reported $307.01M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Accuray USD 456.82M 13.42M Sep/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 884.8M 27.13M Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Chart Industries USD 9.81B 16.6M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Orthofix International USD 850.65M 18.04M Dec/2025
Philips EUR 26.94B 605M Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
Steris USD 10.59B 180.7M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
X T L Biopharmaceuticals USD 714K 7.84M Jun/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025